Tevogen Inc. SEC filings TVGN
Tevogen Inc. has 309 filings in SEC EDGAR's recent list, going back to Jun 10, 2021. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 24, 2026 | — |
| S-8 | Employee stock plan registration | Jul 10, 2026 | — |
| 424B3 | Prospectus | Jun 26, 2026 | — |
| S-3 | Shelf registration | Jun 12, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 4, 2026 | — |
| 424B3 | Prospectus | Feb 26, 2026 | — |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 424B3 | Prospectus | Sep 26, 2025 | — |
| 424B3 | Prospectus | Aug 14, 2025 | — |
| 424B3 | Prospectus | Jul 10, 2025 | — |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| 424B3 | Prospectus | Jun 27, 2025 | — |
| 424B3 | Prospectus | Jun 23, 2025 | — |
| S-3 | Shelf registration | Jun 20, 2025 | — |
| 424B3 | Prospectus | Jun 3, 2025 | — |
| 424B3 | Prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 7, 2025 | — |
| S-8 | Employee stock plan registration | May 1, 2025 | — |
| POS AM | Filing | Apr 30, 2025 | — |
| 424B3 | Prospectus | Jan 28, 2025 | — |
| 424B3 | Prospectus | Nov 19, 2024 | — |
| 424B3 | Prospectus | Aug 26, 2024 | — |
| 424B3 | Prospectus | Aug 23, 2024 | — |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 424B3 | Prospectus | Aug 5, 2024 | — |
| S-1/A | Amended registration statement | Aug 1, 2024 | — |
| S-1/A | Amended registration statement | Jul 23, 2024 | — |
| S-1 | Registration statement | Jun 21, 2024 | — |
| S-8 | Employee stock plan registration | Jun 10, 2024 | — |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| 424B3 | Prospectus | Jan 10, 2024 | — |
| S-4/A | Filing | Dec 22, 2023 | — |
| S-4/A | Filing | Nov 22, 2023 | — |
| S-4/A | Filing | Oct 23, 2023 | — |
| S-4 | Registration for a merger or exchange | Sep 14, 2023 | — |
| 424B4 | Prospectus | Nov 5, 2021 | — |
| S-1/A | Amended registration statement | Oct 29, 2021 | — |
| S-1/A | Amended registration statement | Oct 27, 2021 | — |
| S-1/A | Amended registration statement | Oct 26, 2021 | — |
| S-1/A | Amended registration statement | Oct 22, 2021 | — |
| S-1 | Registration statement | Oct 7, 2021 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TVGN (Nasdaq), TVGNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Warren, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860871
- Former names
- Tevogen Bio Holdings Inc. (until Jul 30, 2026); Semper Paratus Acquisition Corp (until Feb 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.